Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18171221rdf:typepubmed:Citationlld:pubmed
pubmed-article:18171221lifeskim:mentionsumls-concept:C0042214lld:lifeskim
pubmed-article:18171221lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:18171221lifeskim:mentionsumls-concept:C0546816lld:lifeskim
pubmed-article:18171221lifeskim:mentionsumls-concept:C0042207lld:lifeskim
pubmed-article:18171221pubmed:issue1lld:pubmed
pubmed-article:18171221pubmed:dateCreated2008-1-3lld:pubmed
pubmed-article:18171221pubmed:abstractTextPersistence of vaccinia at vaccination sites may help determine the risk associated with secondary transmission. Culture, PCR, and antigen detection were performed on serial vaccination site swab specimens. On day 21 after vaccination, 37% of volunteers were culture positive, most of whom had received vaccine for the first time. Vaccinia is detectable at least through day 21 after vaccination.lld:pubmed
pubmed-article:18171221pubmed:languageenglld:pubmed
pubmed-article:18171221pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18171221pubmed:citationSubsetIMlld:pubmed
pubmed-article:18171221pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18171221pubmed:statusMEDLINElld:pubmed
pubmed-article:18171221pubmed:monthJanlld:pubmed
pubmed-article:18171221pubmed:issn1537-6591lld:pubmed
pubmed-article:18171221pubmed:authorpubmed-author:WortmannGlenn...lld:pubmed
pubmed-article:18171221pubmed:authorpubmed-author:LudwigGeorge...lld:pubmed
pubmed-article:18171221pubmed:authorpubmed-author:HawkesClifton...lld:pubmed
pubmed-article:18171221pubmed:authorpubmed-author:CummingsJames...lld:pubmed
pubmed-article:18171221pubmed:authorpubmed-author:PolhemusMark...lld:pubmed
pubmed-article:18171221pubmed:authorpubmed-author:KloteMaryMlld:pubmed
pubmed-article:18171221pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18171221pubmed:day1lld:pubmed
pubmed-article:18171221pubmed:volume46lld:pubmed
pubmed-article:18171221pubmed:ownerNLMlld:pubmed
pubmed-article:18171221pubmed:authorsCompleteYlld:pubmed
pubmed-article:18171221pubmed:pagination101-2lld:pubmed
pubmed-article:18171221pubmed:meshHeadingpubmed-meshheading:18171221...lld:pubmed
pubmed-article:18171221pubmed:meshHeadingpubmed-meshheading:18171221...lld:pubmed
pubmed-article:18171221pubmed:meshHeadingpubmed-meshheading:18171221...lld:pubmed
pubmed-article:18171221pubmed:meshHeadingpubmed-meshheading:18171221...lld:pubmed
pubmed-article:18171221pubmed:meshHeadingpubmed-meshheading:18171221...lld:pubmed
pubmed-article:18171221pubmed:year2008lld:pubmed
pubmed-article:18171221pubmed:articleTitlePersistence of vaccinia at the site of smallpox vaccination.lld:pubmed
pubmed-article:18171221pubmed:affiliationInfectious Diseases Service, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA.lld:pubmed
pubmed-article:18171221pubmed:publicationTypeJournal Articlelld:pubmed